Ranclic 10%
Ranclic 10% Uses, Dosage, Side Effects, Food Interaction and all others data.
An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as cimetidine and ranitidine. It is generally well tolerated by patients.
Ranclic 10% belongs to a group of medications called antispasmodics/anticholinergics. These medications are used to relieve cramps or spasms of the stomach, intestines, and bladder. Ranclic 10% is used to treat duodenal or stomach ulcers or intestine problems. It can be used together with antacids or other medicine in the treatment of peptic ulcer. It may also be used to prevent nausea, vomiting, and motion sickness.
Trade Name | Ranclic 10% |
Generic | Pirenzepine |
Pirenzepine Other Names | Pirenzepin, Pirenzepina, Pirenzépine, Pirenzepine, Pirenzepinum |
Type | |
Formula | C19H21N5O2 |
Weight | Average: 351.4023 Monoisotopic: 351.169524941 |
Groups | Approved |
Therapeutic Class | |
Manufacturer | |
Available Country | Japan |
Last Updated: | September 19, 2023 at 7:00 am |
Uses
Ranclic 10% is an antimuscarinic agent used to treat peptic ulcers, gastric ulcers, and duodenal ulcers.
For the treatment of peptic ulcer, gastric ulcer, and duodenal ulcer.
Ranclic 10% is also used to associated treatment for these conditions: Gastric Ulcer, Small intestine ulcer
How Ranclic 10% works
Ranclic 10% is a muscarinic receptor antagonist and binds to the muscarinic acetylcholine receptor. The muscarinic acetylcholine receptor mediates various cellular responses, including inhibition of adenylate cyclase, breakdown of phosphoinositides and modulation of potassium channels through the action of G proteins.
Innovators Monograph
You find simplified version here Ranclic 10%